Does REMIMAZOLAM Cause Off label use? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Off label use have been filed in association with REMIMAZOLAM (BYFAVO). This represents 5.8% of all adverse event reports for REMIMAZOLAM.
8
Reports of Off label use with REMIMAZOLAM
5.8%
of all REMIMAZOLAM reports
0
Deaths
3
Hospitalizations
How Dangerous Is Off label use From REMIMAZOLAM?
Of the 8 reports, 3 (37.5%) required hospitalization, and 4 (50.0%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for REMIMAZOLAM. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does REMIMAZOLAM Cause?
Anaphylactic shock (21)
Anaphylactic reaction (11)
Vascular access site occlusion (11)
Cardiac arrest (10)
Hypotension (10)
Oxygen saturation decreased (9)
Blood pressure decreased (8)
Bronchospasm (6)
Circulatory collapse (6)
Drug ineffective (6)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which REMIMAZOLAM Alternatives Have Lower Off label use Risk?
REMIMAZOLAM vs REMODULIN
REMIMAZOLAM vs REPAGLINIDE
REMIMAZOLAM vs REPOTRECTINIB
REMIMAZOLAM vs REQUIP
REMIMAZOLAM vs RESLIZUMAB